These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17440679)

  • 1. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors.
    Guo LH; Schluesener HJ
    Cell Mol Life Sci; 2007 May; 64(9):1128-36. PubMed ID: 17440679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
    Li L; Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2021 Jan; 91():740-755. PubMed ID: 33039660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
    Olson JK; Miller SD
    J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids and innate immunity: taking a toll on neuroinflammation.
    Downer EJ
    ScientificWorldJournal; 2011 Apr; 11():855-65. PubMed ID: 21479354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors in central nervous system glial inflammation and homeostasis.
    Kielian T
    J Neurosci Res; 2006 Apr; 83(5):711-30. PubMed ID: 16541438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases.
    Acioglu C; Heary RF; Elkabes S
    Brain Behav Immun; 2022 May; 102():163-178. PubMed ID: 35176442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Toll-like receptors in CNS response to microbial challenge.
    Konat GW; Kielian T; Marriott I
    J Neurochem; 2006 Oct; 99(1):1-12. PubMed ID: 16899072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.
    Hanke ML; Kielian T
    Clin Sci (Lond); 2011 Nov; 121(9):367-87. PubMed ID: 21745188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological pain and the neuroimmune interface.
    Grace PM; Hutchinson MR; Maier SF; Watkins LR
    Nat Rev Immunol; 2014 Apr; 14(4):217-31. PubMed ID: 24577438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clear and present danger: endogenous ligands of Toll-like receptors.
    Sloane JA; Blitz D; Margolin Z; Vartanian T
    Neuromolecular Med; 2010 Jun; 12(2):149-63. PubMed ID: 19830599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in defense and damage of the central nervous system.
    Aravalli RN; Peterson PK; Lokensgard JR
    J Neuroimmune Pharmacol; 2007 Dec; 2(4):297-312. PubMed ID: 18040848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
    Carty M; Bowie AG
    Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of innate immune responses in the central nervous system.
    Bajramovic JJ
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):4-24. PubMed ID: 21143142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity in the central nervous system.
    Ransohoff RM; Brown MA
    J Clin Invest; 2012 Apr; 122(4):1164-71. PubMed ID: 22466658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of Toll-like receptors in the control of pain and itch.
    Liu T; Gao YJ; Ji RR
    Neurosci Bull; 2012 Apr; 28(2):131-44. PubMed ID: 22466124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate antiviral signalling in the central nervous system.
    Carty M; Reinert L; Paludan SR; Bowie AG
    Trends Immunol; 2014 Feb; 35(2):79-87. PubMed ID: 24316012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.
    Podda G; Nyirenda M; Crooks J; Gran B
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):791-806. PubMed ID: 23812895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
    Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
    Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors are key players in neurodegeneration.
    Arroyo DS; Soria JA; Gaviglio EA; Rodriguez-Galan MC; Iribarren P
    Int Immunopharmacol; 2011 Oct; 11(10):1415-21. PubMed ID: 21616174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.